ILUMYA leaders told to get 1% market share

[anonymous]

A leaked email confirms that the autoimmune drug Ilumya sales management have been notified by the Indian HQ to attain 1% market share in the United States and track to that direction throughout the current year or face being eliminated. The current gross adjusted market share for the drug within the US is .48% according to industry data. “Recently completed management restructuring would make the elimination of that sales force much less disruptive if it were to be assimilated into other selling divisions if needed” commented A—y Gh—-I in the email. It is uncertain what impact, if any, there would be on the stock price should that selling division fail to meet it’s market share goal and be liquidated.

Gathered from Internet Investors Market Watch

 

[anonymous]

A leaked email confirms that the autoimmune drug Ilumya sales management have been notified by the Indian HQ to attain 1% market share in the United States and track to that direction throughout the current year or face being eliminated. The current gross adjusted market share for the drug within the US is .48% according to industry data. “Recently completed management restructuring would make the elimination of that sales force much less disruptive if it were to be assimilated into other selling divisions if needed” commented A—y Gh—-I in the email. It is uncertain what impact, if any, there would be on the stock price should that selling division fail to meet it’s market share goal and be liquidated.

Gathered from Internet Investors Market Watch

This can’t go unacknowledged.

The email came from Abha_ Gand_

Didn’t he join the US and micro- CEO 2016, more than 1.5 years prior to Ill-loo-me-uh’s launch?
Was that not sufficient time for him and his boy-kick to review the strategy, objectives and tactical plans a hundred times?

So why is his *ss not on the chopping block - he’s 6 frickin’ years into this failure and he’s still there? In a real pharma company, he would have been gone in 6 months, max.

 

[anonymous]

LMAO nothing but a dog with fleas . Won't get 1% ever nobody gives a rat's blank as there are far to many better options.

 

[anonymous]

LMAO nothing but a dog with fleas . Won't get 1% ever nobody gives a rat's blank as there are far to many better options.

What brand puts $1B into field sales, marketing, and internal support to get under 1% share in 5 years ?

That’s effffffed up.

Put Ilumya in the bag with Halog and fire the overpaid, self-important ‘biologics’ people.
Start with the guy who had his hands in every decision along the way, Abhay.

 

[anonymous]

A leaked email confirms that the autoimmune drug Ilumya sales management have been notified by the Indian HQ to attain 1% market share in the United States and track to that direction throughout the current year or face being eliminated. The current gross adjusted market share for the drug within the US is .48% according to industry data. “Recently completed management restructuring would make the elimination of that sales force much less disruptive if it were to be assimilated into other selling divisions if needed” commented A—y Gh—-I in the email. It is uncertain what impact, if any, there would be on the stock price should that selling division fail to meet it’s market share goal and be liquidated.

Gathered from Internet Investors Market Watch

Public information shows Sun had Ilumya sales of 143MUSD in FY21. We’ve just started FY23. I don’t know figures for FY22, but let’s be incredibly generous and say there was a 40% YoY increase to 200MUSD.

You’ve spent a billion to be peaking at 200 million in year 5 ?
How can ANYONE associated with the brand or company look themselves in the mirror.

This has to be THE biggest launch failure in the history of Derm if not in all of pharma.

Nicely done !

 

[anonymous]

If you see anyone involved with that loser that has been here for greater than two years they are losers too. Exception being the field reimbursement group that has been struggling to support the non-producing sales group.

 

[anonymous]

This is a classic rumor and panic starting type thread from someone who thinks they have inside scoop and knowledge.

 

[anonymous]

If you see anyone involved with that loser that has been here for greater than two years they are losers too. Exception being the field reimbursement group that has been struggling to support the non-producing sales group.

The threshold for being considered for having blood on your hands is one year at Sun.
If you’ve been there more than a year, you’re part of the problem.

And don’t call out an exception for field reimbursement people - that’s BS.
YOU ALL OWN IT.

 

[anonymous]

Time will tell if the “leaked email” is accurate. Will not know until June 2023 so onto the next topic.

 

[anonymous]

Time will tell if the “leaked email” is accurate. Will not know until June 2023 so onto the next topic.

Yeah, I couldn’t find it online, but regardless, it makes sense from a business perspective. It’s been a dog from Day One and no one can make it bark.
Especially the clowns in Princeton.

 

[anonymous]

A leaked email confirms that the autoimmune drug Ilumya sales management have been notified by the Indian HQ to attain 1% market share in the United States and track to that direction throughout the current year or face being eliminated. The current gross adjusted market share for the drug within the US is .48% according to industry data. “Recently completed management restructuring would make the elimination of that sales force much less disruptive if it were to be assimilated into other selling divisions if needed” commented A—y Gh—-I in the email. It is uncertain what impact, if any, there would be on the stock price should that selling division fail to meet it’s market share goal and be liquidated.

Gathered from Internet Investors Market Watch

Just as Sun India expressed their confidence in Abhay when he got tagged with the insider trading charges, I’m confident that the world-class, award-winning DTC marketers in Princeton will drive share north of 5% in the next year.
How about you ?

 

[anonymous]

Why is it such a dog in Derma ?